M. Q. Lacy

843 total citations
11 papers, 554 citations indexed

About

M. Q. Lacy is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, M. Q. Lacy has authored 11 papers receiving a total of 554 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Hematology. Recurrent topics in M. Q. Lacy's work include Multiple Myeloma Research and Treatments (5 papers), Cancer Treatment and Pharmacology (4 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (4 papers). M. Q. Lacy is often cited by papers focused on Multiple Myeloma Research and Treatments (5 papers), Cancer Treatment and Pharmacology (4 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (4 papers). M. Q. Lacy collaborates with scholars based in United States. M. Q. Lacy's co-authors include Angela Dispenzieri, Morie A. Gertz, S. R. Hayman, Stephen J. Russell, Francis K. Buadi, Nelson Leung, David Dingli, S. Vincent Rajkumar, Shaji Kumar and John A. Lust and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Haematology and Leukemia.

In The Last Decade

M. Q. Lacy

11 papers receiving 544 citations

Peers

M. Q. Lacy
S. R. Hayman United States
Maria Papaioannou Greece
Ivan Pašić Canada
John Higgins United States
Martine Guesnu France
Masaki Toshima Japan
C. Caenazzo Italy
Brandt L. Esplin United States
Loretta Pfannes United States
Noriharu Sato Japan
S. R. Hayman United States
M. Q. Lacy
Citations per year, relative to M. Q. Lacy M. Q. Lacy (= 1×) peers S. R. Hayman

Countries citing papers authored by M. Q. Lacy

Since Specialization
Citations

This map shows the geographic impact of M. Q. Lacy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Q. Lacy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Q. Lacy more than expected).

Fields of papers citing papers by M. Q. Lacy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Q. Lacy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Q. Lacy. The network helps show where M. Q. Lacy may publish in the future.

Co-authorship network of co-authors of M. Q. Lacy

This figure shows the co-authorship network connecting the top 25 collaborators of M. Q. Lacy. A scholar is included among the top collaborators of M. Q. Lacy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Q. Lacy. M. Q. Lacy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
2.
Majithia, Neil, S. Vincent Rajkumar, M. Q. Lacy, et al.. (2016). Early relapse following initial therapy for multiple myeloma predicts poor outcomes in the era of novel agents. Leukemia. 30(11). 2208–2213. 75 indexed citations
3.
Eirin, Alfonso, María V. Irazabal, Morie A. Gertz, et al.. (2011). Clinical features of patients with immunoglobulin light chain amyloidosis (AL) with vascular-limited deposition in the kidney. Nephrology Dialysis Transplantation. 27(3). 1097–1101. 49 indexed citations
4.
Reeder, Craig B., Shaji Kumar, M. Q. Lacy, et al.. (2011). A comparison of lenalidomide/dexamethasone versus cyclophosphamide/lenalidomide/dexamethasone versus cyclophosphamide/bortezomib/dexamethasone in newly diagnosed multiple myeloma. British Journal of Haematology. 156(3). 326–333. 35 indexed citations
5.
Sinha, Shirshendu, Dennis A. Gastineau, Robert Christian Wolf, et al.. (2011). A Cost Effective Analysis of a Risk-Adapted Algorithm for Plerixafor Use in Autologous Peripheral Blood Stem Cell Mobilization. Biology of Blood and Marrow Transplantation. 17(2). S159–S160. 4 indexed citations
6.
Lacy, M. Q., M. A. Gertz, S. R. Hayman, et al.. (2010). Activity of pomalidomide plus dexamethasone (Pom/dex) in dual lenalidomide/bortezomib refractory multiple myeloma (MM).. Journal of Clinical Oncology. 28(15_suppl). 8002–8002. 3 indexed citations
7.
8.
Gertz, Morie A., Nelson Leung, M. Q. Lacy, et al.. (2009). Clinical outcome of immunoglobulin light chain amyloidosis affecting the kidney. Nephrology Dialysis Transplantation. 24(10). 3132–3137. 82 indexed citations
9.
Lorenz, Elizabeth C., M. A. Gertz, Fernando C. Fervenza, et al.. (2008). Long-term outcome of autologous stem cell transplantation in light chain deposition disease. Nephrology Dialysis Transplantation. 23(6). 2052–2057. 65 indexed citations
10.
Simpson, Lijo, S. Vincent Rajkumar, Angela Dispenzieri, et al.. (2008). High incidence of diarrhea in patients on long term therapy with lenalidomide and dexamethasone for multiple myeloma. Journal of Clinical Oncology. 26(15_suppl). 8586–8586. 6 indexed citations
11.
Gertz, Morie A., M. Q. Lacy, & Angela Dispenzieri. (1999). AMYLOIDOSIS. Hematology/Oncology Clinics of North America. 13(6). 1211–1233. 110 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S. R. Hayman Breakdown of academic impact, for papers by Maria Papaioannou Breakdown of academic impact, for papers by Ivan Pašić Breakdown of academic impact, for papers by John Higgins Breakdown of academic impact, for papers by Martine Guesnu Breakdown of academic impact, for papers by Masaki Toshima Breakdown of academic impact, for papers by C. Caenazzo Breakdown of academic impact, for papers by Brandt L. Esplin Breakdown of academic impact, for papers by Loretta Pfannes Breakdown of academic impact, for papers by Noriharu Sato
Rankless by CCL
2026